Press Releases - Pfizer
WEB1 day ago · Pfizer’s BRAFTOVI® + MEKTOVI® Shows Long-Term Clinically Meaningful Response in Patients with BRAF V600E-Mutant Metastatic Non-Small Cell Lung Cancer. 09.11.2024. Research and Pipeline.
Newsroom - Pfizer
WEB6 days ago · Pfizer Launches PfizerForAll™, a Digital Platform that Helps Simplify Access to Healthcare. Pfizer Inc. today introduced PfizerForAll, a user-friendly digital platform designed to make access to healthcare and managing health and wellness more seamless for people across the U.S. Read the Press Release.
CDC identifies possible safety issue with Pfizer’s updated ... - CNN
WEBJan 13, 2023 · The US Centers for Disease Control and Prevention said Friday that there is a possible safety issue with the bivalent Covid-19 vaccine made by Pfizer and BioNTech but that it is unlikely to ...
Pfizer-BioNTech COVID-19 Vaccine COMIRNATY® Receives Full …
WEBAug 23, 2021 · COMIRNATY is the first COVID-19 vaccine to be granted FDA approval. Approval is based on a comprehensive submission package including six-month efficacy and safety data after second dose. More than 1.2 billion Pfizer-BioNTech doses have been delivered to more than 120 countries or territories around the world since December 2020.
Pfizer rolls out another cost-cutting program, sets $1.5 billion …
WEBMay 22, 2024 · U.S. drugmaker Pfizer on Wednesday launched a new multi-year program to reduce its expenses by about $1.5 billion by the end of 2027, adding on to a $4 billion cost cutting plan it announced last...
FDA Approves and Authorizes Updated mRNA COVID-19 Vaccines …
WEBAugust 22, 2024. Today, the U.S. Food and Drug Administration approved and granted emergency use authorization (EUA) for updated mRNA COVID-19 vaccines (2024-2025 formula) to include a monovalent...
Pfizer Inc. (PFE) Latest Stock News & Headlines - Yahoo Finance
WEBGet the latest Pfizer Inc. (PFE) stock news and headlines to help you in your trading and investing decisions.
Pfizer withdraws sickle cell disease treatment on risk of …
WEB1 day ago · Sept 25 (Reuters) - U.S. drugmaker Pfizer (PFE.N), opens new tab said on Wednesday it is withdrawing its sickle cell disease treatment Oxbryta from all markets where it is approved, citing risks ...
FDA Approves Pfizer Vaccine: Live Updates - The New York Times
WEBAug 23, 2021 · Full federal approval for the Pfizer-BioNTech coronavirus vaccine for those 16 and older is opening the way for institutions like the military, corporate employers, hospitals and school...
Pfizer pins hopes on record pipeline to recover from post-Covid …
WEBFeb 21, 2023 · Pfizer expects sales of Comirnaty, the Covid vaccine it developed with German company BioNTech, and its antiviral pill Paxlovid, to fall 62 per cent to $21.5bn in 2023, compared to last year.
- Some results have been removed
Skip to content